MSL Director

Talentmark; New York (NY); Hybrid; USD 180,000 - 230,000; Full time

Job summary

Talentmark is seeking a Director Medical Science Liaison for US East Coast, enabling scientific exchange with KOLs and investigators in haematology/oncology. You will influence clinical development strategy, lead advisory boards, and work closely with Medical Affairs leadership.

Ideal candidates bring early-stage experience (Phase I/II), strong KOL engagement, and the ability to operate with minimal supervision in a growing biotech environment, including significant field travel.

Qualifications

• Experience in haematology and/or oncology.
• Clinical development, preferably early stage (Phase I/II).
• Engagement with KOLs and investigators; advisory board activity.

Responsibilities

• Develop and maintain relationships with KOLs, investigators and clinical sites.
• Provide high-quality scientific exchange around the clinical pipeline.
• Support clinical development, site identification and feasibility.
• Contribute to advisory boards, congresses and other scientific activities.
• Gather and communicate field insights to inform Medical Affairs strategy.
• Help shape Medical Affairs processes and cross-functional collaboration.

Skills

KOL engagement

Scientific exchange

Clinical development

Advisory boards

Independent working

Job description

US East Coast | Emerging Biotech | Field Medical

What if your next MSL role wasn't simply about stepping into an established Medical Affairs model - but about helping shape it?

I'm working with an innovative, emerging biotech that is entering an important phase of clinical development and is looking to appoint a Director Medical Science Liaison to support its US Medical Affairs activities.

This is an opportunity to join a small, science-led organisation where you'll have genuine visibility and influence, working closely with senior Medical Affairs and Clinical Development leadership.

The opportunity

You'll play a key role in developing scientific relationships with KOLs, investigators and clinical sites across haematology/oncology, supporting clinical development and bringing meaningful field insights back into the organisation.

The role will include:

• Developing and maintaining trusted relationships with KOLs and investigators


• Providing high-quality, compliant scientific exchange around the clinical pipeline


• Supporting clinical development, site identification and feasibility


• Contributing to advisory boards, congresses and other scientific activities


• Gathering and communicating field insights to inform Medical Affairs and clinical strategy


• Helping develop Medical Affairs processes, infrastructure and best practice as the organisation grows


• Working cross-functionally with Medical Affairs, Clinical Development and other internal stakeholders

What we're looking for

We're keen to speak with experienced MSLs / Senior MSLs with a strong background in:

• Haematology and/or oncology


• Clinical development, ideally within Phase I/II or an early-stage environment


• KOL and investigator engagement


• Scientific exchange and advisory board activity


• Working independently and operating effectively within a growing organisation

Experience within myeloid malignancies, MPNs, myelofibrosis or related areas would be highly relevant, but we're also interested in strong haem/onc MSLs who can demonstrate transferable expertise.

This could suit someone who enjoys being more than a traditional field-based MSL - someone who wants to build, influence and have a voice in how Medical Affairs develops.

US East Coast territory | Significant field travel

If you're an experienced MSL looking for a chance to make an impact within an ambitious biotech environment, I'd be very happy to have a confidential conversation.